| SNA |
Report |
Diluted EPS |
IN-LINE |
pred ~$4.92 vs. cons ~$4.94 |
MEDIUM |
| SNA |
Report |
Net sales / revenue |
IN-LINE |
pred ~$1.225B vs. cons ~$1.235B |
MEDIUM |
| SNA |
Report |
Tools Group organic sales growth (swing factor) |
MISS |
pred ~+1.5% vs. cons ~+3.5% |
MEDIUM |
| SNA |
Guide |
FY2026 organic sales growth outlook / technician confidence tone |
LOWER |
guide ~+2-3% vs. cons ~+3-4% (FY2026) |
MEDIUM |
| SNA |
Guide |
Corporate expense run-rate (YoY headwind) |
LOWER |
guide ~$28M/qtr vs. cons ~$26M (Q2/quarterly 2026) |
MEDIUM |
| SNA |
Guide |
Full-year effective tax rate |
UNCHANGED |
guide ~22-23% vs. cons ~22.5% (FY2026) |
HIGH |
| SNA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.8% |
— |
MEDIUM |
| SNA |
Return |
5-day cumulative residual |
-3.8% (FOLLOW-THROUGH) |
Stock enters at all-time highs (+16% YTD, ~2% off record) with insider selling and a rich multiple, so the bar is set for durable Tools/tool-storage recovery. A merely in-line EPS/revenue print with decelerating Tools organic growth and Pinchuk's habitual cautious technician-confidence framing ('not declaring victory') undercuts the priced-in 'green shoots keep flowering' narrative. Out-period math works against the stock: even on an EPS in-line, soft Tools organic + higher corporate expense drive modest downward estimate revisions, so an initial gap-down drifts further over 5 days rather than reversing. |
LOW |